Russia announced Wednesday it had approved a second COVID-19 vaccine, as the country recorded a large daily increase in cases and switched to online classes for secondary school in the capital, Moscow.

The new vaccine completed early-stage trials in September and was developed by Siberia’s Vector Institute. The country approved its first vaccine in August. Currently, neither vaccine is in general circulation.

Russia’s coronavirus task force said it had recorded 14,231 new cases Wednesday, the most since the pandemic began, and 239 deaths. More than 4,500 of the new cases were in Moscow.

For more info, please go to
Subscribe to Global News Channel HERE:
Like Global News on Facebook HERE:
Follow Global News on Twitter HERE:
Follow Global News on Instagram HERE:
#GlobalNews #COVID19 #coronavirus